Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2<sup>′</sup>-Bipyridyl

<table>Conductance-concentration relationship of the complexes.</table>

Metal-Based Drugs

fig1

Figure 1

Figure 1: Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2<sup>′</sup>-Bipyridyl 

Figure 1 | Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2′-Bipyridyl 

Metal-Based Drugs

Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2′-Bipyridyl

Figure 1

Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2^′-Bipyridyl